Alembic is currently trading at Rs. 101.41, up by 13.60 points or 15.49% from its previous closing of Rs. 87.81 on the BSE.
The scrip opened at Rs. 95.38 and has touched a high and low of Rs. 103.00 and Rs. 92.21 respectively. So far 1147095 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 107.50 on 21-Feb-2024 and a 52 week low of Rs. 66.00 on 26-May-2023.
Last one week high and low of the scrip stood at Rs. 103.00 and Rs. 85.61 respectively. The current market cap of the company is Rs. 2600.17 crore.
The promoters holding in the company stood at 70.88%, while Institutions and Non-Institutions held 1.11% and 28.01% respectively.
Alembic has reported over 4- fold jump in its net profit at Rs 20.68 crore for the fourth quarter (Q4) ended March 31, 2024 as compared to Rs 4.29 crore for the same quarter in the previous year. Total income of the company increased by 29.92% at Rs 49.46 crore for Q4FY24 as compared Rs 38.07 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported over 4- fold jump in its net profit at Rs 21.29 crore for fourth quarter ended March 31, 2024 as compared to Rs 4.70 crore for the same quarter in the previous year. Total income of the company increased by 30.47% at Rs 51.08 crore for Q4FY24 as compared Rs 39.15 crore for the corresponding quarter previous year.
For the year ended March 31, 2024, the company has reported 17.18% rise in net profit at Rs 92.89 crore as compared to Rs 79.27 crore for the previous year. Total income of the company increased by 10.46% at Rs 206.87 crore for year under review as compared to Rs 187.27 crore for year ended March 31, 2023.
For the year ended March 31, 2024, on the consolidated basis, the company has reported 15.19% rise in its net profit at Rs 92.87 crore as compared to Rs 80.62 crore for the previous year. Total income of the company increased by 10.83% at Rs 212.26 crore for year under review as compared to Rs 191.51 crore for year ended March 31, 2023.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |